Related references
Note: Only part of the references are listed.Prostate cancer: ESMO Consensus Conference Guidelines 2012
A. Horwich et al.
ANNALS OF ONCOLOGY (2013)
Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
Kaoru Okada et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
YB-1: oncoprotein, prognostic marker and therapeutic target?
Annette Lasham et al.
BIOCHEMICAL JOURNAL (2013)
Targeting FOXM1 in cancer
Marianna Halasi et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer
C. Yang et al.
CANCER GENE THERAPY (2013)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
Androgen-responsive Serum Response Factor target genes regulate prostate cancer cell migration
Alissa R. Verone et al.
CARCINOGENESIS (2013)
Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site
Kurtis Eisermann et al.
MOLECULAR CANCER (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
Jordi Codony-Servat et al.
PROSTATE (2013)
Identification of transcription factors associated with castration-resistance: Is the serum responsive factor a potential therapeutic target?
Maria Prencipe et al.
PROSTATE (2013)
Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?
Jianfeng Guo et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice
Jianfeng Guo et al.
BIOMATERIALS (2012)
Translation Initiation Factor eIF4E Is a Target for Tumor Cell Radiosensitization
Thomas J. Hayman et al.
CANCER RESEARCH (2012)
New treatment options for patients with metastatic castration-resistant prostate cancer
Celestia S. Higano
CANCER TREATMENT REVIEWS (2012)
Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice
Jianfeng Guo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
NF-κB and the link between inflammation and cancer
Joseph A. DiDonato et al.
IMMUNOLOGICAL REVIEWS (2012)
Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer
Neha Singh et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2012)
Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
Zoran Culig et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inverse Relationship between PSA and IL-8 in Prostate Cancer: An Insight into a NF-κB-Mediated Mechanism
Yong Xu et al.
PLOS ONE (2012)
Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
Anastasia Malek et al.
PLOS ONE (2012)
Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancer
S. J. Yun et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2012)
NF-κB signaling in prostate cancer: A promising therapeutic target?
Garima Jain et al.
WORLD JOURNAL OF UROLOGY (2012)
Therapeutic Options for Advanced Prostate Cancer: 2011 Update
Aurelius Omlin et al.
CURRENT UROLOGY REPORTS (2012)
Overcoming docetaxel resistance in prostate cancer: a perspective review
Clara Hwang
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
Y-box-binding protein 1 (YB-1) and its functions
I. A. Eliseeva et al.
BIOCHEMISTRY-MOSCOW (2011)
Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?
Jianfeng Guo et al.
BIOTECHNOLOGY ADVANCES (2011)
Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
Hannelore V. Heemers et al.
CANCER RESEARCH (2011)
FGFR-4 Arg388 Enhances Prostate Cancer Progression via Extracellular Signal-Related Kinase and Serum Response Factor Signaling
Wendong Yu et al.
CLINICAL CANCER RESEARCH (2011)
被撤回的出版物: Over-Expression of FoxM1 Leads to Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype in Pancreatic Cancer Cells (Retracted article. See vol. 117, pg. 1963, 2016)
Bin Bao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Transcription Factor Stat5 Knockdown Enhances Androgen Receptor Degradation and Delays Castration-Resistant Prostate Cancer Progression In vivo
Christian Thomas et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Drug resistance in metastatic castration-resistant prostate cancer
Bostjan Seruga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Targeting SP1 Transcription Factor in Prostate Cancer Therapy
Umesh T. Sankpal et al.
Medicinal Chemistry (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027
Peter K. Kaiser et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Transcription Factor Stat3 Stimulates Metastatic Behavior of Human Prostate Cancer Cells in Vivo, whereas Stat5b Has a Preferential Role in the Promotion of Prostate Cancer Cell Viability and Tumor Growth
Lei Gu et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Prioritizing genes associated with prostate cancer development
Ivan P. Gorlov et al.
BMC CANCER (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Forkhead box M1 transcription factor: A novel target for cancer therapy
Zhiwei Wang et al.
CANCER TREATMENT REVIEWS (2010)
Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
Andrew C. Hsieh et al.
CLINICAL CANCER RESEARCH (2010)
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
Stephen Y. Lai et al.
DRUG RESISTANCE UPDATES (2010)
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
Lei Gu et al.
ENDOCRINE-RELATED CANCER (2010)
Molecular cell biology of androgen receptor signalling
Nigel C. Bennett et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Biomaterials offer cancer research the third dimension
Dietmar W. Hutmacher
NATURE MATERIALS (2010)
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
Aimee L. Jackson et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E
C. Andrieu et al.
ONCOGENE (2010)
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
Luc Furic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanisms of transcription factor selectivity
Yongping Pan et al.
TRENDS IN GENETICS (2010)
NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth
Liying Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
Progression of prostate cancer: Multiple pathways to androgen independence
Hong-Lin Devlin et al.
CANCER LETTERS (2009)
RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor-κB Alternative Pathway in Tumorigenicity
Yong Xu et al.
CANCER RESEARCH (2009)
Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression
Qiang Li et al.
CANCER RESEARCH (2009)
eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
Jeremy R. Graff et al.
CANCER RESEARCH (2009)
In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
Robert Snoek et al.
CLINICAL CANCER RESEARCH (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Mechanism of androgen receptor action
Jin Li et al.
MATURITAS (2009)
Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent disease
Elahe A. Mostaghel et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells
Shyh-Han Tan et al.
CANCER RESEARCH (2008)
Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer
Xuesong Ouyang et al.
CANCER RESEARCH (2008)
Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo
Ayush Dagvadorj et al.
CLINICAL CANCER RESEARCH (2008)
HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells
P. J. Maxwell et al.
ONCOGENE (2007)
Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: Evidence for a role for serum response factor in prostate cancer
Hannelore V. Heemers et al.
CANCER RESEARCH (2007)
SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas
Daniel Compagno et al.
PLOS ONE (2007)
被撤回的出版物: Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells (Retracted article. See vol. 78, pg. 5470, 2018)
Zhiwei Wang et al.
CANCER RESEARCH (2007)
Interfering with disease: a progress report on siRNA-based therapeutics
Antonin de Fougerolles et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
Uma R. Chandran et al.
BMC CANCER (2007)
Nuclear factor-κ13 in development, prevention, and therapy of cancer
Carter Van Waes
CLINICAL CANCER RESEARCH (2007)
Strategies for silencing human disease using RNA interference
Daniel H. Kim et al.
NATURE REVIEWS GENETICS (2007)
RNAi therapeutics: a potential new class of pharmaceutical drugs
David Bumcrot et al.
NATURE CHEMICAL BIOLOGY (2006)
Actin' together: serum response factor, its cofactors and the link to signal transduction
Guido Posern et al.
TRENDS IN CELL BIOLOGY (2006)
c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation
S-Y Chen et al.
ONCOGENE (2006)
Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression
Helen Cheng et al.
CANCER RESEARCH (2006)
Toxicity of cationic lipids and cationic polymers in gene delivery
Hongtao Lv et al.
JOURNAL OF CONTROLLED RELEASE (2006)
STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines
W. Zhou et al.
BRITISH JOURNAL OF CANCER (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2
Joyce Wu et al.
CANCER RESEARCH (2006)
Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice
TV Kalin et al.
CANCER RESEARCH (2006)
siRNA-based approaches in cancer therapy
G. R. Devi
CANCER GENE THERAPY (2006)
Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer
G Attard et al.
BJU INTERNATIONAL (2005)
Sp transcription factor family and its role in cancer
S Safe et al.
EUROPEAN JOURNAL OF CANCER (2005)
Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone
RX Wang et al.
SEMINARS IN CANCER BIOLOGY (2005)
Evaluation of potential Stat3-regulated genes in human breast cancer
FC Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo
LF Gao et al.
CLINICAL CANCER RESEARCH (2005)
Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells
P Hååg et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1
S Loeffler et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
NF-kB in development and progression of human cancer
X Dolcet et al.
VIRCHOWS ARCHIV (2005)
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
XB Liao et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
Qing Yang et al.
CANCER CELL INTERNATIONAL (2005)
eIF4E - from translation to transformation
Y Mamane et al.
ONCOGENE (2004)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
The androgen receptor: a potential target for therapy of prostate cancer
AF Santos et al.
STEROIDS (2004)
The role of c-Jun and c-Fos expression in androgen-independent prostate cancer
J Edwards et al.
JOURNAL OF PATHOLOGY (2004)
RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells
SO Lee et al.
PROSTATE (2004)
Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade
HZ Li et al.
CANCER RESEARCH (2004)
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
C Pilarsky et al.
NEOPLASIA (2004)
Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism
N Pore et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
YB-11s upregulated during prostate cancer tumor progression and increases P-glycoprotein activity
P Giménez-Bonafé et al.
PROSTATE (2004)
STAT proteins:: From normal control of cellular events to tumorigenesis
V Calò et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells
ME Wright et al.
MOLECULAR ENDOCRINOLOGY (2003)
YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression
K Jürchott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells
TJ Ahonen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The pleiotropic functions of the Y-box-binding protein, YB-1
K Kohno et al.
BIOESSAYS (2003)
NF-κB nuclear localization and its prognostic significance in prostate cancer
L Lessard et al.
BJU INTERNATIONAL (2003)
The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies
M Kuwano et al.
CANCER SCIENCE (2003)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
NF-kappa B at the crossroads of life and death
M Karin et al.
NATURE IMMUNOLOGY (2002)
Formation of the androgen receptor transcription complex
YF Shang et al.
MOLECULAR CELL (2002)
NF-κB signals induce the expression of c-FLIP
O Micheau et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
